Items where authors include "Janes, SM"

Article

O'Dowd, EL, Lee, RW, Akram, AR et al. (25 more authors) (2023) Defining the road map to a UK national lung cancer screening programme. The Lancet Oncology, 24 (5). e207-e218. ISSN 1470-2045

Crosbie, PAJ, Gabe, R, Simmonds, I et al. (20 more authors) (2022) Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial. European Respiratory Journal, 60 (5). 2200483. ISSN 0903-1936

Lee, DDH, Cardinale, D, Nigro, E et al. (18 more authors) (2021) Higher throughput drug screening for rare respiratory diseases: Readthrough therapy in primary ciliary dyskinesia. European Respiratory Journal, 57 (6). p. 2000455. ISSN 0903-1936

Quaife, SL, Ruparel, M, Dickson, JL et al. (9 more authors) (2020) Reply to Wilson: Improving Lung Cancer Screening Uptake. American Journal of Respiratory and Critical Care Medicine, 202 (8). pp. 1193-1194. ISSN 1073-449X

Crosbie, PAJ, Gabe, R, Simmonds, I et al. (20 more authors) (2020) Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk. BMJ Open, 10 (9). e037075. ISSN 2044-6055

Quaife, SL, Ruparel, M, Dickson, JL et al. (10 more authors) (2020) Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials. American Journal of Respiratory and Critical Care Medicine, 201 (8). pp. 965-975. ISSN 1073-449X

Quaife, SL, Vrinten, C, Ruparel, M et al. (4 more authors) (2018) Smokers' interest in a lung cancer screening programme: a national survey in England. BMC cancer, 18 (1). p. 497. ISSN 1471-2407

Abbosh, C, Birkbak, NJ, Wilson, GA et al. (425 more authors) (2017) Phylogenetic ctDNA analysis depicts early stage lung cancer evolution. Nature, 545. pp. 446-451. ISSN 0028-0836

Quaife, SL, Ruparel, M, Beeken, RJ orcid.org/0000-0001-8287-9351 et al. (8 more authors) (2016) The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’ patients. BMC Cancer, 16. 281. ISSN 1471-2407